Goldman Sachs’s iHuman IH Stock Holding History

Goldman Sachs’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.7K	Buy	+12,626	New	+$20.3K	﹤0.01%	6466
2022 Q1	–	Sell	-46,030	Closed	-$129K	–	6716
2021 Q4	$129K	Buy	+46,030	New	+$198K	﹤0.01%	6061

Other funds holding IH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs's IH Position: Q2 2026 in Review

Goldman Sachs opened a new position in iHuman (IH) in Q2 2026: 12,626 shares worth $17.7K. The stake represents ﹤0.01% of the portfolio and ranks #6466 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in IH as recently as Q4 2021.

Goldman Sachs first reported a position in IH in Q4 2021 and has held it in 2 quarters since. The position peaked at $129K in Q4 2021. 8 funds tracked by Wall St. Rank hold IH as of Q2 2026.

Goldman Sachs held 12,626 shares of iHuman worth $17.7K as of Q2 2026.
iHuman was a new Goldman Sachs position in Q2 2026.
iHuman made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6466 holding.
Goldman Sachs first reported a position in iHuman in Q4 2021 and has held it in 2 quarters since.
Goldman Sachs's iHuman position peaked at $129K in Q4 2021.
8 funds tracked by Wall St. Rank held iHuman as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.